SH2 domain-containing protein 7 (SH2D7)

SH2 domain-containing protein 7 (SH2D7), referenced by the gene symbol LOC646892, appears to be a poorly characterized or uncharacterized protein that contains an SH2 (Src Homology 2) domain. SH2 domains are protein modules found in many intracellular proteins involved in signal transduction, especially tyrosine kinase pathways, where they mediate binding to phosphorylated tyrosine residues on target proteins[1][3][4]. Over 100 human proteins are known to contain SH2 domains, but there is no specific evidence in available literature or public protein databases identifying SH2D7 as a validated or functionally characterized protein with a defined biological role, disease association, or therapeutic relevance. SH2D7 does not appear to be recognized as a drug target, biomarker, or molecular tool in current molecular biology or pharmacology resources. Context: - SH2 domains are critical for *signal transduction* by enabling proteins to interact with phosphorylated tyrosine motifs and are essential in many canonical signaling pathways[1][3][4]. - Many SH2-domain proteins are enzymes, scaffolds, or adapter molecules involved in processes like immune regulation, cell cycle, or growth factor signaling[3][4]. - There are extensively studied SH2 domain-containing proteins (e.g., SH2D1A, Grb2, Lck). SH2D7, in contrast, is not well described in scientific literature or in reviews of the SH2 domain family; it is not mentioned among the 38 recognized SH2-domain protein families in humans[2], nor is it covered in major reviews summarizing functional SH2 proteins[3][4]. - The only information available for "SH2 domain-containing protein 7" is as a gene/protein product of LOC646892, with no evidence for expression, functional role, or disease association. Assessment: - There is nothing to suggest SH2D7 is a validated or commonly used therapeutic or research target. - The gene and protein are poorly characterized and not associated with major signaling pathways, diseases, or pharmacological interest. - There is no evidence for interacting drugs, known biomarkers, or clinical relevance. If you require information about a specific, well-characterized SH2 domain-containing protein (such as SH2D1A, also known as SAP), please specify, as the current target (SH2D7) does not match any established biomedical target or therapeutic context.

Other names

SH2D7SH2 domain-containing protein 7Putative SH2 domain-containing protein LOC646892LOC646892